8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
1/23
1
The Cost of AIDS
and the Role of
Business
J2J
XIV International AIDS Conference
Barcelona, SpainJuly 4, 2002
Mark Schoofs
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
2/23
2
Vicious Cycle Poverty causes
disease
and
Disease causes
poverty
DISEASEPOVERTY
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
3/23
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
4/23
4
AIDS kills people in their
prime Most diseases mainly kill children or the
elderly
AIDS mainly kills people who are: Parents, who leave orphans Teachers and professionals with specialized
knowledge Laborers in factories, farms & mines Subsistence farmers, who provide food for
whole families
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
5/23
5
HIV slows economic growthGrowth Impact of HIV (1990-97) (80 developing countries)
-1.6
-1.4
-1.2
-1
-0.8
-0.6
-0.4
-0.2
0
0 5 10 15 20 25 30 35
HIV Prevalence Rate (%)
R
eduction
ingrowthra
teGDP
percapita
(%,pery
ear)
Source: R. Bonnel (2000) Economic Analysis ofHIV/AIDS, ADF2000 Background paper, World Bank. Slide adapted
from UNAIDS: Socio-Economic Impact of HIV/AIDS in Africa, presented by Anita Alban and Lorna Guiness, ADF
2000.
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
6/23
6
How AIDS weakens
economies Business
Individual workers get sick,lowering productivity
Turnover and absenteeism
lower profitability beyonddirect loss of productivity
Teamworkstablerelationships among keypersonnelis disrupted
Extra people must be hired
for each position
Society Health consumes more of
govt budget, leaving lessfor social investment
Families spend downsavings, reducing capital
Tax revenues fall Skilled workers &
professionals die or mayflee: brain drain
Foreign investment andtourism decline
Mass orphaning
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
7/237
Orphans as a result of
AIDS, Zambia
00
200 000200 000
400 000400 000
600 000600 000
800 000800 000
1 000 0001 000 000
200 000 Number of orphans200 000 Number of orphans
19801980 19901990 20002000 20102010200520051995199519851985 projectionprojection
Source: HIV/AIDS in Zambia, 1997. Slide adapted from UNAIDS: Socio-Economic Impact of HIV/AIDS in Africa, presented by Anita Alban and Lorna
Guiness, ADF 2000.
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
8/238
Rusina Kasongo She lives in Zimbabwe She lost two sons, one
daughter and their
spouses to AIDS Her husband died in an
accident She is raising 10 orphans
alone Studies show orphans are
less likely to go to school*
*For example: In the Central Africa Republic, school enrollment rate among orphans was 39%, two thirds of the national rate of
60%. Source: Survey from CAR, UNICEF, 1999, reported in UNAIDS: Socio-Economic Impact of HIV/AIDS in Africa, presentedby Anita Alban and Lorna Guiness, ADF 2000.
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
9/239
The orphan problem only
gets worse In Africa, grandparentsusually take care oforphans
Orphans are at higher
risk for HIV When orphans produce
orphans, these 2nd -generation orphanshave no grandparents
so are even worse off HIV destroys the
extended-familysupport system
S e c o n d - g e n e r a
T h e y h a v e n oW h o w i l l t a k e c
O r p h a n s
P a r e n t sK i l l e d b y A I
G r a n d p a r e n
Source: Geoff Foster, Family AIDS Caring Trust, Zimbabwe.
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
10/2310
Cloud & Joseph Tineti They live in Zimbabwe
They are 14 and 11
years old.
They have no adultliving with them
The second generation
of orphans will likely bein a similar predicament
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
11/2311
Solution: Keep the parents
alive360
66
$0$50
$100$150$200
$250$300$350$400
Invest
ment
inHe
alth
Econ
omic
Gain
Investing $66 billion inhealth (including AIDS)per year by 2015 yields a6-fold return: $360 billion
in direct earning ofindividuals and fastereconomic growth $66 billion = $13 extra per
person per year in poorcountries, and this moneysaves 8 million lives
annually Plan: Poor countries
invest extra 2% of GDP,rich countries invest 0.1%
USD,billions
Per-capita Health Spenin Low-I ncome Countr
21
38
$0
$5
$10
$15
$20
$25
$30
$35
$40
C u r r e n t s p e n d i n g T a r g e t s p e n d i n g , 2 0 1
Poor- countryshare: $28 bn
Rich-countryshare: $38 bn
Economic gain
Source: Macroeconomics and Health: Investing in Health for Economic Development. Report of
the Commission on Macroeconomics and Health. World Health Organization, 2001
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
12/2312
Russia: the next crisis? Overall HIV adult
prevalence is stillbelow 1%
But between 1996
and 2001, newinfections rose5000%
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
13/23
13
current Russian HIV
epidemic Most current HIV infections are in
injection drug users (IDUs), whooften end up in the institutionsleast able to deal with AIDS:
overcrowded, underfunded jailswhere addiction treatment isscarce and needle-sharing iscommon.
In Russia, sexually-transmitted
disease (STD) rates are high. WillHIV stay in drug users or spread?
Sources: Russian Federal AIDS Center. Ministry of Justice.
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
14/23
14
Russias demographics Russias population is declining, even without HIV
African countries show population growth despite HIV adultprevalence rates of up to 30%
HIV exacerbates Russias population decline A declining population slows economic growth HIV mainly kills young people, so fewer productive Russians will
be alive to generate income for social security systems (such aspensions and health care)
Source: Ruehl C., Pokrovskiy V., Vinogradov V., The Economic Consequences of HIV in Russia, The World Bank Group, 2002,
www.worldbank.org.ru
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
15/23
15
Modeling the economic
effect 17 key variables, such
as: Rate of transmission
among IDUs and from
IDUs to the generalpopulation via sex
Cost of antiretroviraltreatment
Economic parameterssuch as the share of the
labor force with HIV, theshare of govt revenuesused for publicinvestment, & minimumbudgetary expenditures
C u m ula t ive H IVo p t i m i s t ic 1 . 2 3 2 . 3 2 3 . 6 4 5 . 3
( m i ll io n s ) p e s s i m i s t i c 2 . 2 4 5 . 2 5 9 . 6 1 1 4 . 5
G D P l e ve l b a s e l i n e 1 0 . 8 8 1 3 . 5 1 6 . 4 21 9 . 6( rub le s , t i l l i ons )o p t i m i s t i c 1 0 . 8 8 1 3 . 5 1 6 . 3 3 1 9 . 3
pe s s im i s t i c10 .69 13 15 .2 717 . 5
o p t i m i st i c 0 - 0 . 1 5 - 0 . 5 5 - 1 . 2
p e ssim i stic-1 . 7 5-4 . 1 4 -7 -1 0 .
G D P g r o w t h b a s e l in e 4 . 7 1 4 . 0 9 3 . 7 3 . 4
(p e rc e n t) o p tim is t ic 4 .7 4 .0 5 3 .6 3 .2p e s s i m i s t i c4 . 2 3 3 . 5 5 3 . 0 2 2 . 5
o p t i m i s t i c -0 . 2 1-0 . 98 -2 . 7 -4 . 6
p e ssim i stic- 1 0 . 1 9- 1 3 . 2 - 1 8 . 4 - 2 5 .
% c h a n g e
(c om pare d t
b a s e l i n e )
% c h a n g e
(c om pare d t
b a s e l i n e )
World Bank Model for HIV inRussia
available at www.worldbank.org.ru
Source: Ruehl C., Pokrovskiy V., Vinogradov V., The Economic Consequences of HIV in Russia, The World Bank Group, 2002, www.worldbank.org.ru
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
16/23
16
Modeling the economic
effect 17 key variables, such
as: Rate of transmission
among IDUs and from
IDUs to the generalpopulation via sex
Cost of antiretroviraltreatment
Economic parameterssuch as the share of the
labor force with HIV, theshare of govt revenuesused for publicinvestment, & minimumbudgetary expenditures
C u m ula t ive H IVo p t i m i s t ic 1 . 2 3 2 . 3 2 3 . 6 4 5 . 3
( m i ll io n s ) p e s s i m i s t i c 2 . 2 4 5 . 2 5 9 . 6 1 1 4 . 5
G D P l e ve l b a s e l i n e 1 0 . 8 8 1 3 . 5 1 6 . 4 21 9 . 6( rub le s , t i l l i ons )o p t i m i s t i c 1 0 . 8 8 1 3 . 5 1 6 . 3 3 1 9 . 3
pe s s im i s t i c10 .69 13 15 .2 717 . 5
o p t i m i st i c 0 - 0 . 1 5 - 0 . 5 5 - 1 . 2
p e ssim i stic-1 . 7 5-4 . 1 4 -7 -1 0 .
G D P g r o w t h b a s e l in e 4 . 7 1 4 . 0 9 3 . 7 3 . 4
(p e rc e n t) o p tim is t ic 4 .7 4 .0 5 3 .6 3 .2p e s s i m i s t i c4 . 2 3 3 . 5 5 3 . 0 2 2 . 5
o p t i m i s t i c -0 . 2 1-0 . 98 -2 . 7 -4 . 6
p e ssim i stic- 1 0 . 1 9- 1 3 . 2 - 1 8 . 4 - 2 5 .
% c h a n g e
(c om pare d t
b a s e l i n e )
% c h a n g e
(c om pare d t
b a s e l i n e )
World Bank Model for HIV inRussia
available at www.worldbank.org.ru
Decline in Russian GDP
Growth due to HIV
-30
-25
-20
-15
-10
-5
0
2005 2010 2015 2020
Optimistic Pessimistic
Source: Ruehl C., Pokrovskiy V., Vinogradov V., The Economic Consequences of HIV in Russia, The World Bank Group, 2002, www.worldbank.org.ru
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
17/23
17
Effect of HIV Prevention
16
17
18
19
20
2020
Russian GDP:4 Prevention
Scenarios
No HIV
Pessimistic
Effective prevention
Reducing drug use
Effective prevention (cuttingHIV transmission four-fold)results in modest GDP gain
Key reason: Drug use, withnegative impact on economicproductivity continues
Reducing drug use, whichwould also slow the spread ofHIV, results in much larger
improvement Could this data be misused to
stigmatize drug users and tojustify not implementing needleexchange? If so, HIV couldspread more rapidly to general
population
GDP(inrubles,trillions)
Source: Ruehl C., Pokrovskiy V., Vinogradov V., The Economic Consequences of HIV in Russia, The World Bank Group, 2002, www.worldbank.org.ru
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
18/23
18
Effect of antiretroviral
treatment At Western prices, $9000 per
patient per year, treatingwith antiretrovirals (ARVs)actually lowers GDP. It would also consume more
than 80% of the Russianfederal government budget
At $3000, plausible withnegotiation, using ARVsboosts GDP. At $333, close to the current
lowest price, GDP improvesand ARVs consume onlyslightly more of the govtbudget than treating AIDSwithout ARVs
16
16.5
17
17.5
18
Russian GDP:
4 ARV Cost
Scenarios
No ARVs (pessimistic)
ARVs at $9000
ARVs at $3000
ARVs at $333
GDP(in rubles,trillions)
Source: Ruehl C., Pokrovskiy V., Vinogradov V., The Economic Consequences of HIV in Russia, The World Bank Group, 2002, www.worldbank.org.ru
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
19/23
19
Who can take action? Governments NGOs
Individuals Business
Multinationals definitely have the resources Mid-size firms usually have the resources
20,000 South Africans are on ARVs paid by theircompanies medical schemes Often neglected by the press
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
20/23
20
Coca-Cola & Anglo
American Coke (beverages)
Offered marketingexpertise to helpframe prevention
Offered ARVs to itsworkers in Africa But only to its 1,000
directly employedworkers, not to the100,000 workersemployed by itsbottlers
Anglo (mining) Offers good TB and
OI treatment &prevention
2001: Committedto run a feasibilitystudy of ARVs onits mines 2002: Anglo back-
tracked, despite20% of its Africanworkers having HIV
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
21/23
21
Migrant labor spreads HIV Mines needed cheap labor
Housed men in crowdedhostels and didnt allow
families. This system stillexists.
Hard and dangerous work
Prostitution spreads STDs
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
22/23
22
Conclusions Disease causes poverty
But relatively small investments in health can save lives andbolster economies
HIV kills the most productive people, adults in theirprime, which hurts all economies But local factors matter: Russia & Africa have different
epidemics, demographics & economies
Hold business accountable
Are companies shouldering their responsibilities? Do labor practices promote health or illness?
8/7/2019 The Cost of AIDS and the Role of Business (Mark Schoofs)
23/23
23
Acknowledgements Gabriel Rugalema, United Nations
Development Programme Joint United Nations Programme on
HIV/AIDS (UNAIDS) The World Bank Group in Russia Laurie Garrett, Newsday, & Omololu Falobi,
Journalists Against AIDS Nigeria Bob Meyers & Nena Uche, National Press
Foundation The Wall Street Journal and The Village
Voice